← Oncology Approval Tracker

FDA DECISION ·

Opdivo

nivolumab · Bristol Myers Squibb

FDA approvalNew or expanded indicationEsophageal squamous cell carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma after prior fluoropyrimidine and platinum chemotherapy.

LAMPGEN ANALYSIS

Why it matters

Added single-agent checkpoint blockade after standard chemotherapy for squamous esophageal cancer.

What research teams should watch

Verify squamous histology and both prior chemotherapy components; monitor swallowing symptoms and nutrition.

PRIMARY RECORDS

Sources